Macular Telangiectasia Type 1 C4751437
A retinal disorder with abnormal blood vessel development in the macula of one eye, more common in males. May cause gradual vision changes.
Key facts at a glance
- ICD-10
- H53.9
- ICD-11
- 9A00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Photopsia
Blurred central vision
(ophthalmologic)Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Distortion of straight lines (metamorphopsia)
(ophthalmologic)Decreased color perception
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Laser Photocoagulation
Direct laser application to abnormal leaking blood vessels in the macula to reduce edema and prevent further vision loss. Requires careful selection of treatment parameters based on vessel location and leakage severity.
Anti-VEGF Therapy
Intravitreal injections of vascular endothelial growth factor inhibitors to reduce abnormal vessel permeability and leakage. Treatment typically involves a series of injections with regular monitoring of response.
Additional treatment options
Regular Ophthalmologic Surveillance
Scheduled comprehensive eye examinations including OCT imaging to track disease progression and treatment response. Allows early identification of complications requiring intervention.
monitoringCardiovascular Risk Reduction
Smoking cessation, blood pressure management, and control of other vascular risk factors that may contribute to retinal vascular abnormalities. Structured lifestyle modification programs improve overall ocular health outcomes.
lifestyleAntioxidant Supplementation
Nutritional supplements containing antioxidants such as lutein and zeaxanthin to support macular health. May help slow disease progression when combined with conventional treatments.
complementaryMedication Comparisons
Compare medications used to treat Macular Telangiectasia Type 1 C4751437. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy